Simplex Trading’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-4,062
Closed -$188K – 10306
2023
Q2
$188K Sell
4,062
-3,915
-49% -$135K ﹤0.01% 4369
2023
Q1
$228K Buy
7,977
+3,959
+99% +$117K ﹤0.01% 4177
2022
Q4
$125K Buy
+4,018
New +$131K ﹤0.01% 4801
2022
Q3
– Sell
-7,277
Closed -$133K – 11249
2022
Q2
$112K Sell
7,277
-3,566
-33% -$61.3K ﹤0.01% 5430
2022
Q1
$207K Buy
+10,843
New +$194K ﹤0.01% 5104

Simplex Trading's DICE Position: Q3 2023 in Review

Simplex Trading sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 4,062 shares — an estimated $188K sold.

Simplex Trading first reported a position in DICE in Q1 2022 and held it in 5 quarters. The position peaked at $228K in Q1 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

  • Simplex Trading reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Simplex Trading sold 4,062 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $188K.
  • Simplex Trading first reported a position in DICE Therapeutics, Inc. Common Stock in Q1 2022 and held it in 5 quarters.
  • Simplex Trading's DICE Therapeutics, Inc. Common Stock position peaked at $228K in Q1 2023.
  • 0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Simplex Trading's 13F filing for Q3 2023, filed 1 Nov 2023.